Venue: Hyatt Regency San Francisco Airport, San Francisco, California
The event is intended for biopharma executives and aims to provide up-to-date information on manufacturing, outsourcing, capacity management, quality assurance, quality control, regulatory compliance, operational excellence, supply chain, and logistics. It is one of the most senior-level biomanufacturing conferences and networking events in the industry.
Topics
MANUFACTURING AND TECHNOLOGY
- Invest in agility, resiliency and collaboration
- Create flexible, automated multiproduct manufacturing facilities
- Accelerate digital transformations in biomanufacturing and the journey to operational excellence
- Examine data integrity challenges with contract manufacturers
- Review case studies and strategies for rapid manufacturing scale-up
- Reshape manufacturing using digital transformation
- Streamline scale-up and technology transfer to CMOs
QUALITY AND COMPLIANCE
- Establish an eective quality culture in your organization
- Improve Quality Metrics readiness and regulatory expectations
- Implement Quality Systems internally and externally with partners
- Advance PAT to improve Quality Assurance and reduce timelines
- Introduce new technologies to improve cost, quality and efficiency
- Create robust CAPA systems to remediate product quality
- Leverage workforce optimization strategies for improved outcomes
SUPPLY CHAIN AND LOGISTICS
- Navigate supply chain complexity for inventory build and planning
- Examine methods to mitigate risk and avoid product shortages
- Improve supply-chain traceability with track-and- trace serialization
- Develop strategies for managing operations in emerging markets
- Optimize your supply network using automation and real-time data
- Recruit and train high performance biomanufacturing teams
- Supplier risk management strategies
CELL AND GENE THERAPY
- Expanding access of CGT products and keeping pace with changing demands
- Building up manufacturing capabilities to enable improved commercial scale manufacturing
- Navigating the evolving regulatory landscape as it relates to to CGT products
- Perfecting the logistics of assembly and transport of cell-based therapies
- Bridging the gap between commercial and clinical manufacturing operations
- Developing flexible downstream purification techniques
- Tools and techniques to drive innovation within genetic therapeutics
